HCA Healthcare, Inc. (NYSE:HCA) Stock Position Lifted by Harvest Fund Management Co. Ltd

Harvest Fund Management Co. Ltd lifted its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 3.1% in the 3rd quarter, HoldingsChannel reports. The firm owned 1,778 shares of the company’s stock after purchasing an additional 53 shares during the quarter. Harvest Fund Management Co. Ltd’s holdings in HCA Healthcare were worth $723,000 as of its most recent filing with the SEC.

Several other institutional investors have also modified their holdings of HCA. Lee Danner & Bass Inc. acquired a new stake in shares of HCA Healthcare in the second quarter valued at $131,527,000. Darsana Capital Partners LP lifted its holdings in shares of HCA Healthcare by 53.3% in the second quarter. Darsana Capital Partners LP now owns 1,150,000 shares of the company’s stock valued at $369,472,000 after buying an additional 400,000 shares during the period. Swedbank AB acquired a new stake in shares of HCA Healthcare in the first quarter valued at $95,882,000. Argent Capital Management LLC lifted its holdings in shares of HCA Healthcare by 1,215.6% in the second quarter. Argent Capital Management LLC now owns 160,275 shares of the company’s stock valued at $51,493,000 after buying an additional 148,092 shares during the period. Finally, Epoch Investment Partners Inc. lifted its holdings in shares of HCA Healthcare by 16.4% during the second quarter. Epoch Investment Partners Inc. now owns 631,854 shares of the company’s stock valued at $203,002,000 after purchasing an additional 88,948 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In related news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares in the company, valued at $2,415,579. This represents a 29.76 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 21.97 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 15,155 shares of company stock valued at $5,608,990. Insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on the company. Morgan Stanley assumed coverage on HCA Healthcare in a report on Tuesday, September 3rd. They set an “equal weight” rating and a $427.00 target price for the company. KeyCorp reduced their target price on HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating for the company in a report on Monday, October 28th. StockNews.com downgraded HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Raymond James lowered HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday. Finally, Oppenheimer upped their price target on HCA Healthcare from $390.00 to $400.00 and gave the company an “outperform” rating in a research report on Monday, October 28th. One analyst has rated the stock with a sell rating, five have given a hold rating, twelve have issued a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $380.29.

HCA Healthcare Stock Performance

Shares of HCA stock opened at $325.50 on Tuesday. The company has a debt-to-equity ratio of 48.71, a current ratio of 1.12 and a quick ratio of 1.00. HCA Healthcare, Inc. has a fifty-two week low of $245.84 and a fifty-two week high of $417.14. The stock’s 50-day moving average is $377.85 and its two-hundred day moving average is $358.72. The firm has a market cap of $82.45 billion, a P/E ratio of 14.62, a PEG ratio of 1.25 and a beta of 1.68.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Friday, December 13th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.81%. The ex-dividend date is Friday, December 13th. HCA Healthcare’s dividend payout ratio is 11.85%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.